reports
- Research Team
WOOD Daily: MCOVB SS (BUY – initiation of coverage); HTO GA (upgrade t...
HEADLINES: • Medicover: private healthcare pioneer keeps on rolling (BUY - initiation of coverage) • OTE: safe dividend play (upgraded to BUY) • National Bank of Greece: HFSF launches the sale of a 10% stake in NBG NEUTRAL • PCF Group: 2Q24 results in negative territory, below our expectations NEGATIVE • mBank: issues traditional profit warning related to the CHF mortgage saga, ahead of 3Q24E results NEUTRAL • InPost: 4.9% price hike for Allegro NEUTRAL • Allegro: introduction of spirits from 21...
- Bram Buring
- CFA
- Lukasz Wachelko
- CFA
Medicover: private healthcare pioneer keeps on rolling (BUY - initiati...
We initiate coverage of Medicover with a BUY rating and a price target (PT) of SEK 238/share. Medicover provides healthcare and diagnostic services across several European markets - mainly Poland, Germany and Romania - as well as India. It offers a well-tested proposition: healthcare services and facilities that are “a cut above” those offered by the State systems, at prices accessible to the middle classes. The business generated a 2019-23 revenues CAGR of 20%; excluding acquisitions, the top l...
Medicover AB: 1 director
A director at Medicover AB maiden bought 11,170 shares at 144.890SEK and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.